Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Arbutus Biopharma FY 2024 GAAP EPS $(0.38) Up From $(0.44) YoY, Sales $6.17M Down From $18.14M YoY

Author: Benzinga Newsdesk | March 27, 2025 06:43am
Arbutus Biopharma (NASDAQ:ABUS) reported quarterly losses of $(0.38) per share. This is a 13.64 percent increase over losses of $(0.44) per share from the same period last year. The company reported $6.17 million in sales this quarter. This is a 65.98 percent decrease over sales of $18.14 million the same period last year.

Posted In: ABUS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist